狼疮性肾炎患儿透析结局与非狼疮肾小球疾病患儿的回顾性队列比较
本研究基于NAPRTCS登记数据,比较1991-2018年间开始维持透析的6-20岁狼疮性肾炎(LN)患儿(n=231)与非狼疮肾小球疾病患儿(n=1,726)的结局。LN患儿透析起始后第一年住院率更高(63.3% vs 48.6%,P<0.001),且透析后3年内肾移植率更低(0-1年AHR 0.36,1-3年AHR 0.73)。LN与透析期间死亡无关。
要点
- LN患儿透析首年住院率显著高于非狼疮肾小球疾病患儿(63.3% vs 48.6%)。
- LN患儿透析后3年内肾移植率显著低于非狼疮肾小球疾病患儿。
- 贫血与LN患儿透析后住院风险升高独立相关(调整OR 4.44)。
核心结论
- 狼疮性肾炎患儿接受维持透析时,住院风险更高且肾移植率更低,但死亡风险与非狼疮肾小球疾病患儿无显著差异。
研究设计与样本
- 回顾性队列研究,纳入NAPRTCS登记中1991-2018年开始维持透析的6-20岁狼疮性肾炎患儿231例和非狼疮肾小球疾病患儿1,726例。
主要发现
- LN患儿透析起始后第一年住院率为63.3%,非狼疮肾小球疾病患儿为48.6%(P<0.001)。
- LN患儿透析后0-1年肾移植调整风险比(AHR)为0.36(95%CI 0.23-0.57,P<0.001),1-3年AHR为0.73(95%CI 0.54-0.98,P=0.04)。
- 贫血与LN患儿透析后住院相关(调整OR 4.44,95%CI 1.44-13.66,P=0.01)。
- 非白色人种与LN患儿肾移植率降低相关(AHR 0.47,95%CI 0.27-0.82,P=0.01)。
- LN与透析期间死亡无关(AHR 1.21,95%CI 0.47-3.11,P=0.7)。
临床怎么用
- 对狼疮性肾炎透析患儿应加强住院风险管理,尤其关注贫血的纠正。
- 应关注狼疮性肾炎透析患儿肾移植等待名单的登记与推进,尤其非白色人种患儿。
局限性
- NAPRTCS登记未收集狼疮疾病活动度和药物剂量信息,药物使用数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Children with lupus nephritis (LN) are at high risk of developing kidney failure requiring initiation of kidney replacement therapy. This study compared outcomes among children with LN on dialysis with children with non-lupus glomerular disease and investigated risk factors for adverse outcomes among children with LN on dialysis. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: Children and adolescents aged 6-20 years with LN (n = 231) and non-lupus glomerular disease (n = 1,726) who initiated maintenance dialysis 1991-2018 and were enrolled in the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry. EXPOSURE: Lupus nephritis. OUTCOME: Hospitalization, mortality, and time to transplant. ANALYTICAL APPROACH: Contingency tables were used to compare hospitalizations, and multivariable cause-specific hazards models were used to compare rates of death and transplantation in children with LN compared with those with non-lupus glomerular disease. Using data from children with LN, multivariable logistic regression models were fit to evaluate the risk factors for hospitalization, and multivariable Cox regression models were fit to evaluate factors associated with kidney transplantation. RESULTS: Children with LN were more likely to be hospitalized in the first year after dialysis initiation (63.3% vs 48.6%, P < 0.001) and were less likely to receive a kidney transplant in the first 3 years after dialysis initiation (year 0-1: adjusted hazard ratio [AHR], 0.36 [95% CI, 0.23-0.57], P < 0.001; year 1-3: AHR, 0.73 [95% CI, 0.54-0.98], P = 0.04). Anemia was associated with hospitalization after dialysis initiation (adjusted OR, 4.44 [95% CI, 1.44-13.66], P = 0.01). Non-White race was associated with a lower rate of kidney transplantation (AHR, 0.47 [95% CI, 0.27-0.82], P = 0.01). LN was not associated with death while on dialysis (AHR, 1.21 [95% CI, 0.47-3.11], P = 0.7). LIMITATIONS: The NAPRTCS registry does not collect information on lupus disease activity or medication doses and has limited data on medication use. CONCLUSIONS: Children and adolescents with LN on dialysis are at higher risk for adverse outcomes including hospitalization and lower rates of kidney transplantation compared with children with non-lupus glomerular disease receiving maintenance dialysis.
引用
- Wasik H, Chadha V, Galbiati S, et al. Dialysis Outcomes for Children With Lupus Nephritis Compared to Children With Other Forms of Nephritis: A Retrospective Cohort Study. Am J Kidney Dis. 2021. PMID: 34461164. doi:10.1053/j.ajkd.2021.07.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。